Notably, HNSCC frequently perturbs crucial pathways such as p53/RB, EGFR, and PI3K/AKT/mTOR, along with other important molecules that serve as potential therapeutic targets. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.